01 1Emcure Pharmaceuticals
01 1OXALIPLATIN USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-28
Pay. Date : 2013-03-26
DMF Number : 24559
Submission : 2011-01-18
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OXALIPLATIN USP, with a corresponding US DMF Number 24559.
Remarkably, this DMF maintains an Active status since its submission on January 18, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 28, 2013, and payment made on March 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
